Aims-To determine the expression ofp53, Rb, and bcl-2 during the cell cycle in stimulated peripheral blood lymphocytes (PBLs) and microwave heated reactive lymphoid tissue sections.
M S Mateo, M Sanchez-Beato, J C Martinez, A Orfao, J L Orradre, M A Piris Abstract Aims-To determine the expression ofp53, Rb, and bcl-2 during the cell cycle in stimulated peripheral blood lymphocytes (PBLs) and microwave heated reactive lymphoid tissue sections. Methods-The expression of p53, Rb and bcl-2 proteins in paraffin wax embedded tonsil tissue sections was detected by immunohistochemistry using an (APAAP) technique following microwave irradiation. Flow cytometric analysis as performed on phytohaemagglutinin (PHA) stimulated PBLs, with simultaneous S fraction determination. Results-Expression of p53 protein was detected in reactive tonsil germinal centre cells, in some suprabasal cells in the surface and cryptic epithelium, and in some endothelial cells. Analysis of p53 in PHA stimulated PBLs revealed expression of p53 by non-tumoral activated lymphocytes. Rb protein expression was increased in PHA stimulated PBLs and was usually detected in most germinal centre B cells, in isolated paracortical cells, in a fraction of endothelial cells, and in most epithelial suprabasal cells. Expression of bcl-2 in stimulated lymphocytes was inversely correlated with proliferation. This confirms findings in reactive tonsil tissue samples, where proliferating cells located in the germinal centres and paracortical area are mostly bcl-2 negative. Conclusions-Expression of these three oncogenic and tumour suppressor proteins varies during the cell cycle in non-tumoral cells. Consequently, tumoral growth fraction must be taken into account when analysing dysregulation of these three genes in lymphomas and other tumours. The p53 protein may be detected in benign conditions, as its expression is not synonymous with malignancy or mutation of the p53 gene. Sequential study of transformation in a variety of lesions (ranging from reactive to neoplastic) indicates that carcinogenesis is a multistep process involving mutation. This includes the activation of oncogenes inducing growth promotion, as well as inactivation of growth suppressor genes.' The final consequence of this genetic dysregulation is the loss of control of normal cell proliferation and differentiation. Oncogenes, or tumour supressor genes, involved in lymphomagenesis include the p53, bcl-2 and the retinoblastoma (Rb) genes.
The p53 tumour suppressor gene is located on the short arm of chromosome 17, which encodes a nuclear phosphoprotein that plays an important role in the negative control of cell proliferation and regulation of the cell cycle.2A Moreover, p53 plays a fundamental role in the prevention of genomic instability. Following DNA damage, concentrations of the p53 protein increase, blocking progression along the cell cycle in the G1/S checkpoint, permitting DNA repair or inducing apoptosis;5 p53 also pro- 11 20 The importance of this expression can only be determined by comparing normal expression of these proteins in non-tumoral cells. Antigen retrieval techniques have recently become available,24 enabling more precise characterisation of the expression of these three proteins in resting and activated lymphocytes in nontumoral conditions.
Methods
Ten paraffin wax embedded reactive tonsil tissue samples from routine tonsillectomy specimens were obtained from the archives of the Pathology Department, "Virgen de la Salud" Hospital, Toledo. Normal peripheral blood was obtained from voluntary healthy donors. Peripheral blood lymphocytes (PBLs) were isolated by HISTOPAQUE (Sigma) density gradient centrifugation and washed in RPMI-1640 medium. Cells were kept at 37°C in a 5% CO2 humidified incubator in cell culture flasks, at 2 x 10 cells/ ml RPMI-1640 medium, supplemented with 10% fetal calf serum, 2 mM L-glutamine, and 2% phytohaemagglutinin (PHA) (Gibco, BRL). Aliquots of the activated cells were harvested every 24 hours and prepared for flow cytometry analysis.
Paraffin wax embedded reactive tonsil tissue sections were stained using the alkaline phosphatase-antialkaline phosphatase (APAAP) technique, as described previously.25
For detection of p53 protein, the following anti-p53 antibodies were used: Pab 1801 (Serotec), 1801 (Biogenex), CM1 (Novocastra), D07 (Novocastra), D07 (Biogenex), BP53 (Biogenex), and BP53-12 (Zymed), all ofwhich specifically detect human wild-type and mutant p53. Anti-bcl-2 monoclonal antibodies used included bcl-2 100 and 124 (IgGl and IgG2a isotypes, respectively) (kindly provided by Dr D Y Mason22). The Rb protein was detected using the anti-Rb monoclonal antibody PMG3-245 (Pharmingen),26 which binds both phosphorylated and unphosphorylated forms.
Growth fraction was assessed by MIB-1 monoclonal antibody, which recognises a Ki67 epitope that survives formalin fixation and embedding in paraffin wax.27 All paraffin wax sections were heated in a microwave oven in a sodium citrate solution before incubation with antibody.24 Paraffin wax sections were dewaxed with xylene, rehydrated in alcohol, and placed in Coplin jars filled with a 0-01 M tri-sodium citrate solution, and heated twice in a conventional microwave oven for six minutes at 700 W. While undergoing microwave processing, slides were always covered with buffer. After heating, slides were permitted to cool at room temperature for 15 minutes. They were then quickly washed in TRIS buffered saline (pH 7 4), and incubated with specific antibody.
Quantitative immunohistochemical investigation with a computer analysis system (CAS 200) was used to score individual PBLs for the presence of bcl-2 cytoplasmic protein.
The total optical density of the immunostained area against that of the cellular area was calculated by the image analyser. The cellular area and staining in 70 single cells in each case were measured, and the values obtained presented graphically. Linear regression statistical analysis was undertaken to establish whether there was any correlation between cell size (related to cell cycle phase) and bcl-2 protein staining.
FLOW CYTOMETRY
Expression of p53, bcl-2 and Rb was also studied using flow cytometric analysis of PHA activated lymphocytes. Flow cytometry was performed using a FACSORT instrument (Becton/ Dickinson, San Jose, California, USA), equipped with a double discrimination module. Cell cycle analysis was carried out using CELLFIT software package for data acquisition and analysis. Analysis or protein expression was undertaken using the LYSIS II software program.
For detection of the three proteins by immunofluorescence, fixation/permeabilisation for optimal immunodetection was performed with paraformaldehyde/Triton X-100 (PFT) according to Aiello (fig 1 C) , as well as in some suprabasal cells in the surface and cryptic epithelium ( fig 1E) . Reactivity was nuclear in all cases, although in some mitotic cells the signal was observed throughout the cyto-p53, Rb and bcl-2 expression during the cell cycle15 Figure 2 Immunofluorescence analysis of p53, Rb and bcl-2 expression in PHA stinmulated PBLs. A: p53 reactivitiy from days 0 to 3. Cells were divided into large and small subsets. Peak 1, snmall cells; peak 2, large cells. The increase in1 the number ofp53 positive cells in conjunction wzith cell cycle activation appears to be restricted mainly to the large cell subset. B: Increased MFI of Rb expression after 72 hours of stimulationi is restricted to the large cell subset. C: Fluorescence histograms show a decrease in bcl-2 expression as the cell cycle progressed. The fraction of positive cells present in each sample was calculated after subtracting the negative isotype matched control histogram.
plasm. Occasional p53 positive twin nuclei were also present (fig 1 D) . In most cases lymphoid positive cells were large with no other distinctive morphological features. MIB-1 staining in parallel tonsil tissue sections revealed that the parabasal layer with p53 positive cells also expressed maximum staining for this marker ( fig 1L) .
Flow cytometric analysis of the p53 fluorescence of PHA stimulated PBLs revealed an increase from day 0 (19 30) 3) . As a further control, the experiment was repeated with both phycoerythrin and FITC, giving similar results.
Cells were sub-divided into large and small, based on forward scatter (FSC) (which relates to the size of the cell) versus size scatter (SCC) (which relates to internal granularity) dot plots obtained using flow cytometry. The increase in the number of p53 positive cells as the cell cycle progressed was mainly restricted to the large cells (fig 2A) . Rb 1K) . Consecutive staining of the same germinal centres for MIB-1 showed an inverse correlation between both markers, since the area staining most strongly for MIB-1 corresponded to the dark zone of the germinal centre, where fewer bcl-2 positive cells were observed. Some mitotic figures exhibited weak cytoplasmic positivity. In all cases reactivity was mainly confined to cytoplasm. In the interfollicular area the same staining gradient was found, larger cells being bcl-2 negative. Basal bcl-2 positive epithelial cells were situated below the layer of p53, Rb, and MIB-1 positive cells (figs lE, 1G, and IL).
Flow cytometric analysis of bcl-2 positive PHA stimulated PBLs showed a decrease in the MFI from 108 on day 0 to 48&57 on day 3, with a cgncurrent increase in the rate of the cell cycle ( figs 2C and 3) .
To confirm the decrease in the level of bcl- 
